Cell Dissociation Market Key Insights Based on Product Type, End-use and Regional Demand

SDKI Inc. published a new report on "Cell Dissociation Market-Global Forecast 2030". This study includes the statistical and analytical approaches needed to grow the cell dissociation market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-109568

The cell dissociation market is estimated to reach a market value of approximately US $ 804 million by 2030, from a market value of approximately US $ 346 million in 2022, and is expected to grow at a CAGR of 12.8% during the forecast period. Factors driving this market growth include increased government funding for chronic disease research and increased R & D investment in pharmaceutical and biotechnology companies. In addition, emerging economies such as China, India and Brazil offer favorable growth opportunities for players operating in the cell dissociation market. In addition, cell dissociation is an indispensable activity in biopharmacy research because it is directly related to drug development and elucidation of pathological conditions. As a result, increased spending on R & D activities by biopharmacy companies is driving the growth of this market.

Market segment

The cell dissociation market is by product (enzyme (collagenase, trypsin, DNase, elastase), non-enzyme, equipment / accessories), type (tissue dissociation, cell ablation), tissue (binding, epithelium), end user. Divided by (pharmaceutical, laboratory) and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

The non-enzyme product segment is expected to grow at the fastest rate during the forecast period.

Based on the product, the market is divided into enzyme dissociation products, non-enzyme dissociation products, and equipment / accessories. The non-enzyme product segment is estimated to grow at a maximum CAGR during the forecast period. This can be primarily due to benefits such as out-of-the-box and inherently non-toxic.

Tissue dissociation type segments are expected to dominate the cell dissociation market during the forecast period.

Based on the type, the market is divided into tissue dissociation and cell detachment. The tissue dissociation segment dominated the market in 2017. Increasing demand for enzyme products and equipment / accessories in pharmaceutical and biotechnology companies is a major driver of this segment.

Regional Overview

The cell dissociation market is further subdivided based on the region, and the market growth of each country is evaluated. These include North America (US, Canada, and other North America), Europe (Germany, France, Italy, Spain, United Kingdom, and other Europe), Asia Pacific (China, Japan, India, Australia, and other Asia Pacific). ) And other regions.

The North American region dominates the cell dissociation market, followed by Europe. The large share of North America may be due primarily to increased research in the pharmaceutical and biotechnology industry and the strong presence of key market players in the region. However, the Asia Pacific region is estimated to grow at the fastest rate during the forecast period. This growth may be due to infrastructure development in the life sciences industry, increased government investment in chronic disease research, and the presence of emerging economies such as China and India.

Major key players

Key players in the cell dissociation market include Thermo Fisher Scientific (USA), Merck KGaA (Germany), Roche (Switzerland), MiltenyiBiotec (Germany), HiMedia Laboratories (India), STMCELL Technologies (Canada), BD (USA). , ATCC (USA), PAN-Biotech (Germany), GE Healthcare (USA) and more. The study includes a detailed competitive analysis of these major companies in the cell dissociation market, corporate profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/reports/cell-dissociation-market/109568

Contact Us

Hina Miyazu
15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc. Company Profile

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.